Prelude Therapeutics secures $60M from Incyte option deal
Go back to Prelude Therapeutics secures $60M from Incyte option deal| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 117.25 +0.60 (0.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $116.65 | 52 Week High | $118.49 | |||
| Open | $116.27 | 52 Week Low | $55.00 | |||
| Day High | $119.60 | P/E | N/A | |||
| Day Low | $116.27 | EPS | $-0.56 | |||
| Volume | 2,232,513 | |||||
| (NASDAQ: PRLD) | Delayed: 4.20 +0.02 (0.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.18 | 52 Week High | $ | |||
| Open | $4.08 | 52 Week Low | $ | |||
| Day High | $4.31 | P/E | N/A | |||
| Day Low | $4.01 | EPS | $ | |||
| Volume | 180,698 | |||||
